{"id":8564,"date":"2013-07-16T05:15:10","date_gmt":"2013-07-16T09:15:10","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=8564"},"modified":"2013-07-16T05:15:10","modified_gmt":"2013-07-16T09:15:10","slug":"analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564","title":{"rendered":"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 07\/16\/2013 (wallstreetpr) &#8211;\u00a0Ascendiant Capital Markets provided coverage in the shares of the Synthetic Biologics Inc (NYSEMKT:SYN) on a research note issued for investors on Tuesday. The report said that Synthetic Biologics was in collaboration with Intrexon Corporation, the company\u2019s last venture, with the CEO Randal J Kirk. The vision with which Intrexon has been moving forward was to reduce the time, cost and risk which have been associated with the new bio industrial technologies that were to be used by Synthetic Biologics. Making use of the Intrexon propriety technologies, Synthetic Biologics is developing a gamut of monoclonal antibody for the treatment of serious contagious infectious diseases. The company has two monoclonal antibodies being prepared in the pre clinical stage. These two mAb are focused on curing the Acinetobacter and Pertussis infections.<\/p>\n<p style=\"text-align: justify;\">The share price of the company rose 1.18% on Tuesday, reaching $1.77. Synthetic Biologics is also known as Adeona Pharmaceuticals, a biotech company which focuses on the production of synthetic deoxyribonucleic acid for treating serious illnesses.<\/p>\n<p style=\"text-align: justify;\">CFO of Synthetic Biologics Inc (NYSEMKT:SYN) to attend OneMedForum in NYC<\/p>\n<p style=\"text-align: justify;\">It has been reported that the CFO of Synthetic Biologics Inc (NYSEMKT:SYN), John Monahan, shall be present in the 6<sup>th<\/sup> Annual meet for the OneMedForum NYC conference on 27<sup>th<\/sup> June at the New York Metropolitan Club. Mr. Riley, along with C. Evan Ballantyne and the CFO, shall sit to have a one to one conversation with the investors and analysts who will attend the meeting and have registered for the conference. The <a href=\"http:\/\/onemedplace.com\/forum\/webcast\/\">live webcast<\/a> shall be aired.<\/p>\n<p style=\"text-align: justify;\">After the meeting, the archived one will be shown for 30 days from the conference at the Synthetic Biologics website <a href=\"http:\/\/www.google.com\/url?q=http%3A%2F%2Fwww.syntheticbiologics.com&amp;sa=D&amp;sntz=1&amp;usg=AFQjCNHupOW4rLY8bxRdBD3MS-M_ds9rlg\" target=\"_blank\">www.syntheticbiologics.com<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 07\/16\/2013 (wallstreetpr) &#8211;\u00a0Ascendiant Capital Markets provided coverage in the shares of the Synthetic Biologics Inc (NYSEMKT:SYN) on a research note issued for investors [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":8565,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[2884,2883],"stock_ticker":[],"class_list":["post-8564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-nysemktsyn","tag-synthetic-biologics-inc-nysemktsyn","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 07\/16\/2013 (wallstreetpr) &#8211;\u00a0Ascendiant Capital Markets provided coverage in the shares of the Synthetic Biologics Inc (NYSEMKT:SYN) on a research note issued for investors [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-07-16T09:15:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN)\",\"datePublished\":\"2013-07-16T09:15:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\"},\"wordCount\":292,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg\",\"keywords\":[\"NYSEMKT:SYN\",\"Synthetic Biologics Inc (NYSEMKT:SYN)\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\",\"name\":\"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg\",\"datePublished\":\"2013-07-16T09:15:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564","og_locale":"en_US","og_type":"article","og_title":"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN) - Wall Street PR","og_description":"Boston, MA 07\/16\/2013 (wallstreetpr) &#8211;\u00a0Ascendiant Capital Markets provided coverage in the shares of the Synthetic Biologics Inc (NYSEMKT:SYN) on a research note issued for investors [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-07-16T09:15:10+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN)","datePublished":"2013-07-16T09:15:10+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564"},"wordCount":292,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg","keywords":["NYSEMKT:SYN","Synthetic Biologics Inc (NYSEMKT:SYN)"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564","url":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564","name":"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg","datePublished":"2013-07-16T09:15:10+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/07\/Medicines-and-Drugs-in-the-Palm-of-My-Hand1.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/analysts-of-ascendiant-capital-markets-cover-synthetic-biologics-inc-nysemktsyn-8564#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Analysts of Ascendiant Capital Markets cover Synthetic Biologics Inc (NYSEMKT:SYN)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/8564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=8564"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/8564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/8565"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=8564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=8564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=8564"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=8564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}